Literature DB >> 27639407

Consensus Document of the Spanish Society of Cardiology and the Spanish Society of Internal Medicine on the diagnosis and treatment of iron deficiency in heart failure.

N Manito1, J M Cerqueiro2, J Comín-Colet3, J M García-Pinilla4, A González-Franco5, J Grau-Amorós6, J R Peraira7, L Manzano8.   

Abstract

Iron deficiency in patients with heart failure is a medical problem of recent particular interest. This interest has resulted from the publication of several clinical trials that demonstrated that the administration of intravenous iron to such patients improved their functional capacity and even reduced the number of hospitalisations for heart failure decompensation. However, applying the evidence from these studies in clinical practice is still controversial, both in terms of the diagnostic criteria for iron deficiency (absolute and functional) and the optimal method for iron replenishment. This article is a consensus document that integrates the recommendations of the Spanish Society of Internal Medicine and the Spanish Society of Cardiology. The article reviews the scientific evidence and proposes a diagnostic and therapeutic performance protocol for iron deficiency in heart failure.
Copyright © 2016 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.

Entities:  

Keywords:  Anaemia; Anemia; Déficit de hierro; Heart failure; Hierro intravenoso; Insuficiencia cardiaca; Intravenous iron; Iron deficiency

Year:  2016        PMID: 27639407     DOI: 10.1016/j.rce.2016.08.001

Source DB:  PubMed          Journal:  Rev Clin Esp (Barc)        ISSN: 2254-8874


  3 in total

Review 1.  Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management.

Authors:  Maria Domenica Cappellini; Josep Comin-Colet; Angel de Francisco; Axel Dignass; Wolfram Doehner; Carolyn S Lam; Iain C Macdougall; Gerhard Rogler; Clara Camaschella; Rezan Kadir; Nicholas J Kassebaum; Donat R Spahn; Ali T Taher; Khaled M Musallam
Journal:  Am J Hematol       Date:  2017-07-07       Impact factor: 10.047

2.  Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction.

Authors:  Raquel López-Vilella; Silvia Lozano-Edo; Patricia Arenas Martín; Pablo Jover-Pastor; Meryem Ezzitouny; José Sorolla Romero; María Calvo Asensio; Julia Martínez-Solé; Borja Guerrero Cervera; José Carlos Sánchez Martínez; Víctor Donoso Trenado; Ignacio Sánchez-Lázaro; Luis Martinez Dolz; Luis Almenar Bonet
Journal:  ESC Heart Fail       Date:  2021-12-28

3.  Prevalence and determinants of iron deficiency in cardiac amyloidosis.

Authors:  Antoine Jobbé-Duval; Mélanie Bézard; Stéphane Moutereau; Mounira Kharoubi; Silvia Oghina; Amira Zaroui; Arnault Galat; Coraline Chalard; Elisabeth Hugon-Vallet; Francois Lemonnier; Damien Eyharts; Elsa Poulot; Pascale Fanen; Benoit Funalot; Valérie Molinier-Frenkel; Vincent Audard; Luc Hittinger; Marc Antoine Delbarre; Emmanuel Teiger; Thibaud Damy
Journal:  ESC Heart Fail       Date:  2022-02-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.